Market Place
Sourcing Support
All News #Library
Rare Diseases
Fulcrum Therapeutics Announces Positive 12-Week Pociredir Results
24 Feb 2026 //
GLOBENEWSWIRE
Fulcrum Therapeutics Hosts Investor Event For PIONEER Trial Data
02 Dec 2025 //
GLOBENEWSWIRE
Fulcrum Therapeutics To Unveil Pociredir Data In Sickle Cell
03 Nov 2025 //
GLOBENEWSWIRE
Fulcrum Therapeutics at Leerink Partners Global Healthcare Conf.
04 Mar 2025 //
GLOBENEWSWIRE
Fulcrum Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
11 Oct 2024 //
GLOBENEWSWIRE
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Rule
13 Sep 2024 //
GLOBENEWSWIRE
Sanofi gambles $80M on Fulcrum’s muscular dystrophy drug
14 May 2024 //
BIOPHARMADIVE
Fulcrum CEO leaves for new opportunity, company starts search for replacement
04 Jan 2023 //
ENDPTS
Fulcrum Announces USFDA Grants Fast Track Designation to Losmapimod for FSHD
12 May 2021 //
GLOBENEWSWIRE
Fulcrum Therapeutics gets off $80M series B round
05 Sep 2018 //
FIERCE BIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.